Masaya Hasegawa
Okazaki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Soy lysolecithin attenuates hypertension and behavioral impairments in mice fed a high-salt diet through receptor-specific regulation of prostaglandin signaling and arachidonic acid-derived prostaglandin production.
Journal: Neurochemistry international
Published: March 05, 2026
Kynureninase deficiency ameliorated monocytic recruitment and severity in a mouse model of multiple sclerosis.
Journal: Neurochemistry international
Published: November 25, 2025
Targeting the noradrenergic-metabolic axis: A new strategy for sugar-induced depression subtypes.
Journal: British journal of pharmacology
Published: July 29, 2025
Maternal immune activation induces neurodevelopmental impairments of adult offspring through alterations in tryptophane-kynurenine pathway in the placenta.
Journal: Biochemical and biophysical research communications
Published: October 19, 2024
Chronic stress induces behavioural changes through increased kynurenic acid by downregulation of kynurenine-3-monooxygenase with microglial decline.
Journal: British journal of pharmacology
Published: August 14, 2024
Autism spectrum disorder-like behaviors induced by hyper-glutamatergic NMDA receptor signaling through hypo-serotonergic 5-HT1A receptor signaling in the prefrontal cortex in mice exposed to prenatal valproic acid.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: April 10, 2024
Soy lysolecithin prevents hypertension and cognitive impairment induced in mice by high salt intake by inhibiting intestinal inflammation.
Journal: Neurochemistry international
Published: March 29, 2024
Diagnoses and new therapeutic strategy focused on physiological alteration of tryptophan metabolism
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Published: March 29, 2023
High salt induces cognitive impairment via the interaction of the angiotensin II-AT1 and prostaglandin E2-EP1 systems.
Journal: British journal of pharmacology
Published: February 14, 2023
Last Updated: 09/26/2026